Close Menu

Locus Biosciences is trying to combat so-called superbugs — bacteria that are resistant to many antibiotics — by engineering the bacteriophages that naturally infect them, NPR reports.

The firm, it says, is using CRISPR to develop a mix of three phages to target particular bacterial genes, that way the treatment only targets particular bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.